Company Filing History:
Years Active: 1991
Title: The Innovations of Lloyd Kenneth O
Introduction
Lloyd Kenneth O is a notable inventor based in the Bronx, NY (US). He has made significant contributions to the field of medical research, particularly in the area of blood group antigens. His work has implications for cancer diagnosis and other medical applications.
Latest Patents
Lloyd Kenneth O holds a patent for a "Monoclonal antibody panel for blood group A antigen." This patent includes monoclonal antibodies HT29-36, CB, CLH6, M2, and S12, which are instrumental in determining the presence of Type A blood group antigen. These antibodies are particularly useful in distinguishing different forms of the antigen, which can vary slightly. This innovation is crucial for making fine distinctions between the different forms of Type A antigen, enhancing diagnostic capabilities in cancer and related fields.
Career Highlights
Lloyd is affiliated with the Sloan Kettering Institute for Cancer Research, where he continues to advance his research and innovations. His work at this prestigious institution underscores his commitment to improving medical diagnostics and treatment options.
Collaborations
Lloyd has collaborated with esteemed colleagues such as Koichi Furukawa and Hanrik Clausen, contributing to a rich environment of innovation and research.
Conclusion
Lloyd Kenneth O's contributions to the field of medical research through his patent on monoclonal antibodies exemplify the impact of innovation in healthcare. His work not only enhances our understanding of blood group antigens but also paves the way for advancements in cancer diagnosis.